KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Retained Earnings: 2009-2025

Historic Retained Earnings for Charles River Laboratories International (CRL) over the last 16 years, with Sep 2025 value amounting to $1.9 billion.

  • Charles River Laboratories International's Retained Earnings fell 8.41% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year decrease of 8.41%. This contributed to the annual value of $1.8 billion for FY2024, which is 3.98% down from last year.
  • Charles River Laboratories International's Retained Earnings amounted to $1.9 billion in Q3 2025, which was up 2.88% from $1.9 billion recorded in Q2 2025.
  • Charles River Laboratories International's Retained Earnings' 5-year high stood at $2.1 billion during Q3 2024, with a 5-year trough of $686.9 million in Q1 2021.
  • Over the past 3 years, Charles River Laboratories International's median Retained Earnings value was $1.9 billion (recorded in 2023), while the average stood at $1.9 billion.
  • As far as peak fluctuations go, Charles River Laboratories International's Retained Earnings skyrocketed by 107.47% in 2021, and later decreased by 8.41% in 2025.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Retained Earnings stood at $980.8 million in 2021, then soared by 46.10% to $1.4 billion in 2022, then spiked by 31.71% to $1.9 billion in 2023, then dropped by 3.98% to $1.8 billion in 2024, then fell by 8.41% to $1.9 billion in 2025.
  • Its Retained Earnings stands at $1.9 billion for Q3 2025, versus $1.9 billion for Q2 2025 and $1.8 billion for Q1 2025.